Press Release
May 9, 2018
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018
More
May 3, 2018
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018
More
March 26, 2018
Amphastar Pharmaceuticals to Present at the Needham’s 17th Annual Healthcare Conference
More
March 21, 2018
Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.
More
March 12, 2018
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017
More
March 5, 2018
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018
More
November 29, 2017
Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP
More
November 20, 2017
Amphastar Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference
More
November 8, 2017